Liposome-based combination therapy for acne treatment


EROĞLU İ., Aslan M., Yaman U., Gultekinoglu M., ÇALAMAK S., KART D., ...More

JOURNAL OF LIPOSOME RESEARCH, vol.30, no.3, pp.263-273, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 3
  • Publication Date: 2020
  • Doi Number: 10.1080/08982104.2019.1630646
  • Journal Name: JOURNAL OF LIPOSOME RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, MEDLINE
  • Page Numbers: pp.263-273
  • Keywords: Acne vulgaris, liposome, tetracycline, tretinoin, combination treatment, IN-VITRO RELEASE, TOPICAL TRETINOIN, IMPROVE OUTCOMES, GLOBAL ALLIANCE, DERMAL DELIVERY, TETRACYCLINE, FORMULATIONS, MANAGEMENT, EPIDEMIOLOGY, ANTIBIOTICS
  • Hacettepe University Affiliated: Yes

Abstract

Acne vulgaris is one of the most common chronic diseases worldwide with the high prevalence ratio of about 80-85% in patients who are in puberty period. For the treatment options, many conventional dosage forms are available; however, existing limitations of systemic administration of drugs (oral antibiotics), such as adverse events and resistance, led for seek of new formulation options. In this study, liposomes containing tetracycline HCl and tretinoin were prepared by the film formation method. In vitro characterization studies revealed that liposomes (111.10 +/- 8.02 nm; P.D.I.=0.198 +/- 0.03; Z.P.=25.83 +/- 0.40 mV) with an encapsulation efficiency more than 80% for both APIs were formulated. In order to maintain a suitable viscosity for topical application, optimized liposomal formulations were dispersed in carbopol-based gel. In vitro release of APIs was sustained for 24 hours with released amounts of 56.44% and 58.44% for tetracycline HCl and tretinoin, respectively. Stability evaluation of both liposomes and liposomes in hydrogels was investigated for 6 months at 4 degrees C and 25 degrees C; and no statistically significant change was observed in terms of particle size, zeta potential, encapsulation efficiency, appearance, pH, and viscosity. Cytotoxicity tests confirmed the nontoxic structure of liposomal gel formulations on mice fibroblast cells. In addition, antibacterial efficacy has been proven with Staphylococcus aureus and Streptococcus epidermidis strains as well as the effect on biofilm formation and eradication. As a result, we hereby presented a new combination drug product, which consists of dual active ingredients having comedolytic and bacteriostatic effects in a single, safe, and stable liposome formulation.